Pathophysiologioal Effects of Nicotine on the Pancreas

Experimental Biology and Medicine

Volumn 218, Issue 3, 1998, Pages 168-173

  Chowdhury, Parimal ^a   Rayford, Phillip L ^a   Chang, Louis W ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

DRUG EFFECT; GASTROINTESTINAL TRACT FUNCTION; GENE EXPRESSION; HUMAN; NONHUMAN; PANCREAS; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; GENE EXPRESSION; HUMANS; NICOTINE; PANCREAS; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; SMOKING;

EID: 0031841668     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (110)

1. Miller, NS. Nicotine addiction as a disease. In The Clinical Management of Nicotine Dependence. Cocores JA, Ed. New York: Springer-Verlag, pp66-78, 1991.
2. Surgeon General. The Health Consequences of Using Smokeless Tobacco. Bethesda, MD: USPHS, NIH Publ. #86-2874, 1986.
3. U.S. Public Health Service: Smoking and health. A report of the Surgeon General, Department of Health, Education and Welfare. Public Health Service, Office of the Assistant Secretary for Health. Office of Smoking and Health (DHEW Publication No. PHS79-50066). Washington, D.C.: U.S. Government Printing Office, pp13-41, 1979.
4. Fernandez E, Vecchia CL, Porta M, Negri E, d'Avanzo B, Boyle, P. Pancreatitis and the risk of pancreatic cancer. Pancreas 11:185-189, 1995.
5. Wynder EL, Mabuchi K, Maruchi N, Fortner JG. Epidemiology of cancer of the pancreas. J Natl Cancer Inst 50:645-667, 1973.
6. Gold EB, Cameron JL. Chronic pancreatitis and the risk of pancreatic cancer. N Eng J Med 323:1485-1486, 1993.
7. Lowenfels AB, Maisonneuve P, Cavalline G, Andersen JR, Dimigno EP, Andren-Sandberg A, Domiloff L. International Pancreatitis Study Group Pancreatitis and risk of pancreatic cancer. N Eng J Med 328:1433-1437, 1993.
8. Mack TM, Yu MC, Hanisch R, Henderson BE. Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 76:49-60, 1986.
9. Farrow DC, Davis S. Risk of pancreatic cancer in relation to medical history and use of tobacco, alcohol, and coffee. Int J Cancer 45:816-820, 1990.
10. Silverman DT, Dunn JA, Hoover RN, Schiffman M, Lillmoe KD, Schoenberg JB, Brown LM, Greenberg RS, Hayes RB, Swanson GM, Wacholder S, Swartz AG, Liff JM, Pattern LM. Cigarette smoking and pancreas cancer: A case control study based on direct interviews. J Natl Cancer Inst 86:1510-1516, 1986.
11. Miller BA, Silverman DT, Kaplan R. Pancreas. In: Miller BA, Ries LA, Hanky BF, Eds. Cancer Statistics Review 1973-1990 Bethesda. MD: NCJ, NIH Publ No. 93-2789, 1993.
12. Olsen GW, Mandel JS, Gibson RW, Wattenberg LW, Schuman LM. A case control study of the pancreatic cancer and cigarettes, alcohol, coffee, and diet. Am J Public Health 79:1016-1018, 1989.
13. Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, Runia S, Boyle P. Life time history of smoking and exocrine carcinoma of the pancreas: A population-based case control study in the Netherlands. Int J Cancer 49:816-822, 1991.
14. Zatonski WA, Boyle P, Przewozniak K, Maisonneuve P, Drosile K, Walker AM. Cigarette smoking, alcohol, tea, and coffee consumption and pancreas cancer risk: A case control study from Opole, Poland. Int J Cancer 53:601-607, 1993.
15. Howe GR, Jain M, Burch JD, Miller AB. Cigarette smoking and cancer of the pancreas: Evidence from a population-based case control study in Toronto, Canada. Int J Cancer 47:323-328, 1991.
16. U.S. Dept of Health and Human Services. The Health Benefits of Smoking Cessation: A report of Surgeon General, 1990. Washington. D.C.: CDC PHS DHHS, DHHS Publ. No. (CDC) 90-8416, 1990.
17. Rivenson A, Hoffman D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived nitrosamines. Cancer Res 48:6912-6917, 1988.
18. Pour PM, Rivenson A. Induction of a mixed ductal-squamous-islet cell carcinoma in a rat treated with a tobacco-specific carcinogen. Am J Pathol 134:627-631, 1989.
19. Chowdhury P, Rayford PL, Chang LW. Inductions of pancreatic acinar cell pathology via inhalation of nicotine. Proc Soc Exp Biol Med 20:159-164, 1992.
20. Chowdhury P, Hosotani R, Chang LW, Rayford PL. Metabolic and pathologic effects of nicotine on the gastrointestinal tract and pancreas of rats. Pancreas 5:222-229, 1990.
21. Chowdhury P, Ami M, Hosotani R, Rayford PL. Meal stimulated exocrine pancreation and release of GI peptides in normal and nicotine-treated rats. Regul Pep 33:11-20, 1991.
22. Dubick MA, Palmer R, Lau PP, Morrill RR, Geokas MC. Altered exocrine pancreatic function in rats treated with nicotine. Toxicol Appl Pharmacol 96:132-139, 1988.
23. Majumder APN, Davis GA, Dubick MA, Geokas MC. Nicotine stimulation of protein secretion from isolated rat pancreatic acini. Am J Physiol 248:G158-G163, 1985.
24. Lau PP, Dubick MA, Yu GSM, Morill PR, Geokas MC. Dynamic changes of pancreatic structure and function of rats treated chronically with nicotine. Toxicol Appl Pharmacol 104:457-465, 1990.
25. Chowdhury P, Doi R, Tangoku A, Rayford PL. Structure and functional changes of rat exocrine pancreas exposed to nicotine. Int J Pancreatol 18:257-264, 1995.
26. Hammond DK, Bjercke RJ, Langone JJ, Strobel HW. Metabolism of nicotine by rat liver cytochromes P-450. Drug Metab Dispos 19:804-808, 1991.
27. Nakayama H, Okuda H, Nakashiwa T, Imaoka S, Funae Y. Nicotine metabolism by rat hepatic cytochrome P450 S. Biochem Pharmacol 45:2554-2556, 1993.
28. Lombardi B, Estes LW, Longnecker DS. Acute hemorrhagic pancreatitis (massive necrosis) with fat necrosis induced in mice by DL-ethionine with a choline-deficient diet. Am J Pathol 79:464-480, 1975.
29. Niderau C, Ferrell LD, Grendall JH. Caerulein-induced acute necrotizing pancreatitis in mice: Protective effects of proglumide, benzotript, and secretin. Gastroenterology 88:1192-1204, 1985.
30. Watanabe I, Baccino FM, Steer ML, Meldolesi J. Supromaximal cerulein stimulation and ultra structure of rat pancreatic acinar cells: Early morphological alterations during development of experimental pancreatitis. Am J Pathol 246:G457-G467, 1984.
31. Koike K, Steer ML, Meldolesi J. Pancreatic effects of ethiorine. blockage of exocytosis, and appearance of crinophagy and autophagy preceding cellular necrosis. Am J Physiol 242:G297-G307, 1982.
32. Adler G, Hahn C, Kern HF, Rao KN. Caerulein-induced pancreatitis in rats: Increased lysosomal enzyme activity and autophagocytosis. Digestion 32:10-18, 1985.
33. Niderau C, Grendall JH. Intracellular vacuoles in experimental acute pancreatitis in rats and mice are an acidified compartment. J Clin Invest 81:229-236, 1988.
34. Rao K, Zuretti N, Raccino M, Lombardi B. Acute hemorrhagic pancreatitis in mice: The activity of lysosomal enzymes in the pancreas and liver. Am J Pathol 98:45-60, 1980.
35. Niderau C, VanDyke RW, Scharschmidt BF, Grendall JH. Rat pancreatic zymogen granules: An actively acidified compartment. Gastroenterology 91:1433-1442, 1986.
36. Steer ML, Meldolesi J, Figarella C. Pancreatitis: The role of lysosomes. Dig Dis Sci 29:934-938, 1984.
37. Yamaguchi H, Kimura T, Mimura K, Nawata H. Activation of proteases in caerulein-induced pancreatitis. Pancreas 4:565-571, 1989.
38. Murthy SNS, Dinoso VP Jr., Clearfield HR, Chey WY: Simultaneous measurements of basal, pancreatic, gastric acid secretion, plasma gastrin, and secretin during smoking. Gastroenterology 73:758-761, 1977.
39. Konturek SJ, Solomon TE, McGreight WG, Johnson LR, Jacobson WD. Effect of nicotine on gastrointestinal secretions. Gastroenterology 13:361-365, 1972.
40. Bynum TE, Solomon TE, Johnson LR, Jacobson ED. Inhibition of pancreatic secretion in man by cigarette smoking. Gut 13:361-365, 1972.
41. Solomon TE, Solomon N, Shanbour LL, Jacobson ED. Direct and indirect effects of nicotine on rabbit pancreatic secretion. Gastroenterology 67:276-283, 1974.
42. Chowdhury P, Bone RC, Louria DB, Rayford PL. Effect of cigarette smoke on human trypsin inhibitory capacity and antitrypsin concentrations. Am Rev Resp Dis 126:177-179, 1982.
43. Richter JM, May RJ. Disorders of the pancreas. In: Pathology of the gastrointestinal diseases. Chopra S, May RJ, Eds. Boston/Toronto/London: Little Brown & Co., pp529-573, 1990.
44. Bloom SR. Clinical syndromes of gut hormones. In: Thompson JC, Ed. Gastrointestinal Endocrinology, Receptors and Postreceptor Mechanisms, Academic Press, Inc.: San Diego, pp479-490, 1990.
45. Kontuerek SJ. Gastrointestinal hormones and gastric secretion. In: Jerzy GD, Ed. Gastrointestinal Hormones. New York: Raven Press, pp529-564, 1990.
46. Chey WY. Gastrointestinal hormones, pancreatic biliary and intestinal secretins. In: Jerzy GD, Eds. Gastrointestinal Hormones. New York: Raven Press, pp565-586, 1980.
47. Williams JA, Korc M, Dormer RL. Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini. Am J Physiol 235:E517-E524, 1978.
48. Schmidt J, Lewandrowski K, Fernandez-del Castillo, Mandarelli U, Compton CE, Warshaw AL, Rattner DW. Histopathologic correlates of serum amylase activity in acute experimental pancreatitis. Dig Dis Sci 37:1426-1433, 1992.
49. Agarwal N, Pitchumoni CS, Sivaprasad AV. Evaluating tests for acute pancreatitis. Am J Gastroenterol 85:356-366, 1990.
50. Nordestgaard AG, Wilson SE, Williams RA. Correlation of serum amylase levels with pancreatic pathology and pancreatitis etiology. Pancreas 3:159-161, 1988.
51. Dubick MA, Mar G, Mayer AD, MaJumder APN, McMahon MJ, Geokas MC. Digestive enzymes and protease inhibitors in plasma from patients with acute pancreatitis. Pancreas 2:187-194, 1987.
52. Andriulli A, Masoero G, Amato A, Felder M, Benitti V, Dobrilla G, Delpierre M, Verme G. Serum immunoreactive catioric trypsinogen response to secretin in normal subjects. Am J Gastroenterol 78:579-583, 1983.
53. Williams JA, Hootman SR. Stimulus-secretion coupling in pancreatic acinar cells. In: Gro VLW, Brooks FB, Dimagno EP, Eds. Exocrine Pancreas: Biology, Pathology and Diseases. New York: Raven Press, pp 123-139, 1986.
54. Besterman HS, Adrian TE, Bloom SR, Christofides ND, Mallinson CN, Ponti V, Lombardo L, Modigliani R, Guerin S, South M. Pancreatic and gastrointestinal hormones in chronic pancreatitis. Digestion 24:195-208, 1982.
55. Bruzzone R. The molecular basis of enzyme secretion. Gastroenterology 99:1157-1176, 1990.
56. Doi R, Chowdhury P, Rayford PL. Agonist-regulated alteration of the affinity of pancreatic muscarinic cholinergic receptors. J Biol Chem 268:22436-22442, 1993.
57. Brannon PM. Primary cultures of pancreatic acinar cells. In: Thompson JC, Ed. Gastrointestinal Endocrinology Receptors and Post-Receptor Mechanisms. Academic Press, Inc.: San Diego, pp199-209, 1990.
58. Brannon PM, Orisson DM, Kretchmer N. Primary cultures of rat pancreatic acinar cells in serum-free medium. In Vitro Cell Dev Biol Anim 21:6-14, 1985.
59. Bruzzone R. The molecular basis of enzyme secretion. Gastroenterology 99:1157-1176, 1990.
60. Neer EJ. Heterotrimeric G proteins: Organizer of transmembrane signals. Cell 80:249-257, 1995.
61. Doi R, Chowdhury P, Nishikawa M, Takaori K, Inoue K, Imamura M, Rayford PL. Carbachol and cholecystokinin enhance accumulation of nicotine in rat pancreatic acinar cells. Pancreas 10:154-160, 1995.
62. Hillard CJ. Neurochemistry of nicotine. In: Watson RR, Eds. Drugs of Abuse and Neurobiology. CRC Press, Inc., pp85-114, 1992.
63. Wonnacott S. The paradox of nicotine acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11:216-219, 1990.
64. 3 H] acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 45:427-433, 1985.
65. Schwartz RD, Keller KJ. Nicotine cholinergic receptor binding sites in the brain: Regulation in vivo. Science 220:214-216, 1983.
66. Marks MJ, Burch JB, Collins AC. Effects of chronic nicotine infusion on tolerance development and nicotine receptors. J Pharmacol Exp Ther 226:817-825, 1983.
67. Marks MJ, Stitzel JA, Collins A. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 235:619-628, 1985.
68. 3H] nicotine binding sites in human brain. J Neurochem 50:1243-47, 1988.
69. Miledi R, Parker I, Schalow G. Transmitter-induced calcium entry across postsynaptic membrane of frog end plates measured using arsenazo III. J Physiol 300:197-212, 1980.
70. 45Ca influx, and secretion of catecholamines. Neuroscience 15:283-292, 1985.
71. Cena V, Nicholasm GP, Sanchez-Garcia P, Kirpekar SM, Garcia AG. Pharmacological dissection of receptor-associated and voltage-sensitive ionic channels involved in catecholamine release. Neuroscience 10:1455-1462, 1983.
72. Boarder M, Mariott D, Adams M. Stimulus secretion coupling in cultured chromaffin cell dependency on external sodium and on dihydropyridine sensitive calcium channels. Biochem Pharmacol 36:163-167, 1987.
73. Hillard CJ. Effects of nicotine and nicotine agonist on calcium influx into brain synaptosomes. NIDA Res Mongraph 81:324, 1988.
74. Burgoyne RD. The relationship between secretion and intracellular free calcium in bovine adrenal chromaffin cells. Biosci Rep 4:605-611, 1984.
75. Eberhard DA, Holtz RW. Cholinergic stimulation on inositol monophosphate formation in bovine adrenal chromaffin cells: Distinct nicotinic and muscarinic mechanisms. J Neurochem 49:1634-1643, 1987.
76. Firestone JA, Browning MD. Calcium signaling in bovine adrenal chromaffin cells: Additive effects of histamine and nicotine. Synapse 17:268-274, 1994.
77. Nakaki T, Sasakawa N, Yamamoto S, Kato R. Functional shift for muscarinic to nicotinic cholinergic receptors involved in inositol triphosphate and cyclic GMP accumulation during primary culture of adrenal chromaffin cells. Biochem J 251:397-403, 1988.
78. Sasakawa N, Nakaki T, Kato R. Rapid increases in inositol penkis-phosphate accumulation by nicotine in cultured adrenal chromaffin cells. FEBS Lett 261:378-380, 1990.
79. 2+ influx causes rapid translocation of protein kinase C to membranes. J Biol Chem 262:18873-18879, 1988.
80. 2+i] in rat sublingual mucous acini by stimulating neurotransmitter release from presynaptic terminals. Proc Soc Exp Biol Med 207:292-301, 1994.
81. Hillard CJ, Graf WK. Studies of the effect of nicotine on synaptosomal calcium accumulation using Fura-2. NIDA Res Monograph 165:331-332, 1990.
82. Travoli S, Komiecki J, Petralia S, Basergna R. Oncogenes in growth and development. FASEB J 4:3209-3214, 1990.
83. Hunter T. Cooperation between oncogenes. Cell 64:249-270, 1991.
84. Cowley B, Chadwick L, Grantham J, Calvert J. Sequential protooncogene expression in regenerating kidney following acute renal injury. J Biol Chem 264:8389-8393, 1989.
85. Iovanna JL, Lechene de La Porte PL, Dagom JC. Expression of genes associated with dedifferentiation and cell proliferation during pancreatic regeneration following acute pancreatitis. Pancreas 7:712-771, 1992.
86. Iovanna JL, Keim V, Michel R, Dagorn JC. Pancreatic gene expression is altered during acute experimental pancreatitis in the rat. Am J Physiol 261:485-489, 1991.
87. Sloman D, Cline M. Expression of cellular oncogenes during embryonic and fetal development of the mouse. Proc Natl Acad Sci USA 81:7141-7145, 1984.
88. Zimmerman K, Yancopoulos G, Collum R, Smith RK, Kohl NE, Denis KA, Nan MM, Witle ON, Toran-Allerand D, Gee CE, Minna JD, Alt FW. Differential expression of myc-family genes during marine development. Nature 319:780-783, 1986.
89. Muller R, Slamon D, Tremblay J, Cline M, Verma I. Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature 299:640-644, 1982.
90. Calvo E, Dusseti N, Cadenn MB, Dagorn JC, Iovanna JL. Changes in gene expression during pancreatic regeneration: Activation of c-myc and H-ras oncogenes in the pancreas. Pancreas 6:150-156, 1991.
91. Montague DC, Chowdhury P, Chang LW, Lyn-Cook BD. Chronic inhalation of nicotine affects the H-ras gene and its expression in pancreatic acinar cells in vivo. Proc Am Soc Canc Res 34: A869, 1993.
92. Chowdhury P, Doi R, Lyn-Cook BD, Montague DC, Chang LW, Rayford PL. Inhalation of nicotine enhances mutant p21 protein expression of rat pancreatic acinar cells in conjunction with pathological changes. Gastroenterology 104:A392, 1993.
93. Chowdhury P, Montague DC, Rayford PL, Chang LW and Lyn-Cook BD. Nicotine alters pancreatic gene (H-ras) expression and induces point mutation and exocrine pancreatic injury. XVI Proc Int Cancer Congress. New Delhi. India, 1994. Rao RS, Deo MG, Sanghvi LD, Mitra I, Eds. Bologna, Italy: Monduzzi Editoire (Published), pp369-373.
94. Alonso T, Srivastava S, Santos E. Alterations of G-protein coupling function in phosphoinositide signaling pathways of cells transformed by ras and other membrane-associated and cytoplasmic oncogenes. Mol Cell Biol 10(6):3117-3124, 1990.
95. Gibbs JB, Marshall MS, Scolnick EM, Dixon RAF, Vogel US. Modulation of guanine nucleotides bound to ras in NIH3T3 cells by oncogenes. growth factors, and the GTPase activating protein (GAP). J Biol Chem 265(33):20437-20442, 1990.
96. Valencia A, Kjeldgaard M, Pal EF, Sander C. GTPase domains of ras p21 oncogene protein and elongation factor Tu: Analysis of three-dimensional structures, sequence families, and functional sites. Proc Natl Acad Sci USA 88:5443-5447, 1991.
97. Schanne FAX, Kane AB, Young EE, Farber JL. Calcium dependence of toxic cell death: A final common pathway. Science 206:700-702, 1979.
98. Chien KR, Farber JL. Microsomal membrane dysfunction in ischemic liver cells. Arch Biochem Biophys 180:191-198, 1997.
99. Majumdar APN, Vesenka GD, Dubick MA, Geokas MC. Evaluation of the role of calcium in cytotoxic injury in isolated rat pancreatic acini. Biochem Biophys Res Commun 139:530-537, 1986.
100. Haubruck H, McCormick F. Ras p21: Effects and regulation. Biochem Biophys Acta 1072:215-229, 1991.
101. Marx J. Two major signal pathways linked. Science 262:988-990, 1993.
102. Mulachy LS. Nature 313:241, 1985.
103. Beitel GJ, Clark SG, Horritz HR. Caenorhabditis elegans ras gen let-60 acts as a switch in the pathway of vulvae induction. Nature 348:503-509, 1990.
104. Simon MA, Bowtell DDL, Dodson GS, Laverty TR, Rubin GM. Ras 1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the seven less protein tyrosine kinase. Cell 67:701-716, 1991.
105. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: A conserved switch for diverse cell functions. Nature 348:125-132, 1990.
106. Capella G, Cronauer-Mitra S, Peinado MA, Perucho M. Frequency and spectrum of mutations at condons 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect 93:125-131, 1991.
107. Barbacid M. Ras genes. Ann Rev Biochem 56:779-827, 1987.
108. Marx J. Forging a path to the nucleus. Science 260:1588-1590, 1993.
109. Lowy DR, Zhang K, DeClue JE, Williamsen BM. Regulation of p21 ras activity. Trends Genetics 7:346-351, 1991.
110. Wetscher GJ, Bagchi M, Bagchi D, Perdikis G, Hinder PR, Glaser K, Hinder RA. Free radical production in nicotine-treated pancreatic tissue. Free Radic Biol Med 18:877-882, 1995.